Ashly E. Jordan, PhD, MPH
NYS Office of Addiction Services and Supports (OASAS) - Director of Research and Program Evaluation
Email: Ashly.Jordan@oasas.ny.gov
Education
PhD, Epidemiology, Graduate School of Public Health and Health Policy, City University of New York MPH, Biostatistics and Epidemiology, School of Public Health, City University of New York
Research Interests
Societal (structural, social, and political) determinants of population health and inequities, infectious disease epidemiology, people who use drugs, hepatitis C virus, HIV, multi-level data analysis BIO
Ashly Jordan is the Director of Research and Program Evaluation for the New York State Office of Addiction Services and Supports. She is an interdisciplinary epidemiologist with more than 15 years of applied research experience and public health practice focused on understanding how systems and interventions can improve health and social outcomes for people who use substances and who experience addiction. She has served as a consultant to the United Nations Office on Drugs and Crime. Dr. Jordan’s research has examined blood-borne and skin and soft tissue infections, tuberculosis, drug overdose, substance use epidemiology, and the impact of criminal legal involvement on substance use epidemiology and treatment trajectories. She has published extensively, including on prevention and care continua, Big Events theory, and novel metrics, and has served on study sections. Drawing on theory-based multi-level understanding of illness and health, and principles of health equity and social justice, Dr. Jordan’s research and public health practice has focused on the interplay between individual, social and structural factors on people who use substances. Projects
Principal Investigator, Leveraging Regulatory Flexibility for Methadone Take-home Dosing to Improve Retention in Treatment for Opioid Use Disorder: A Stepped-wedge Randomized Trial to Facilitate Clinic Level Changes. Active
Principal Investigator, NY MOVES: Evaluating the Impact of New York’s Methadone Outreach VEhicleS. Active
Publications
Recent
Renteria D, Fawole A, Alexandre J, Allen H, Aleksanyan J, Choi S, Liebmann E, Hong S, Jordan AE, Grady MO, Drury V, Kawola S, Del Rosario J, Lincourt P, Neighbors CJ (2026).
Too young for medication? Prescriber perspectives on how age shapes medication for opioid use disorder prescribing in transition-age adults
Harm Reduction Journal [Epub 2026 May 22]. doi: 10.1186/s12954-026-01467-1.
Too young for medication? Prescriber perspectives on how age shapes medication for opioid use disorder prescribing in transition-age adults
Harm Reduction Journal [Epub 2026 May 22]. doi: 10.1186/s12954-026-01467-1.
O'Rourke A, Saloner B, Ruelas-Vargas K, Krawczyk N, Jordan AE, Jette G, Miller M, Song M, Harris SJ, Frank D, Gibbons JB, Curriero FC (2026).
Demonstrating the potential for utilizing mobile methadone units to serve medically institutionalized populations in New York State
Journal of Substance Use and Addiction Treatment, 188, 209981. doi: 10.1016/j.josat.2026.209981.
Demonstrating the potential for utilizing mobile methadone units to serve medically institutionalized populations in New York State
Journal of Substance Use and Addiction Treatment, 188, 209981. doi: 10.1016/j.josat.2026.209981.
Drury V, Aleksanyan J, Narayanan N, Echenique J, Melkonian M, Renteria D, Fawole A, Choi S, Kawola S, del Rosario J, Lincourt P, Morris ML, Neighbors CJ, Cunningham CO, Jordan AE (2026).
Beyond age: Transition age adults have distinct identities, substance use patterns compared with other adults in substance use disorder treatment
Journal of Addiction Medicine [Epub 2026 Apr 14]. doi: 10.1097/ADM.0000000000001692.
Beyond age: Transition age adults have distinct identities, substance use patterns compared with other adults in substance use disorder treatment
Journal of Addiction Medicine [Epub 2026 Apr 14]. doi: 10.1097/ADM.0000000000001692.
Estrada Y, Helmy HL, Jordan AE, Trinidad AJ, Dominguez Gomez L, Zaidi I, Sauer J, Harocopos A (2026).
Piloting a point-of-care drug-checking service at syringe service programs in New York City
Substance Use & Addiction Journal, 47 (2), 564-569. doi: 10.1177/29767342251376805.
Piloting a point-of-care drug-checking service at syringe service programs in New York City
Substance Use & Addiction Journal, 47 (2), 564-569. doi: 10.1177/29767342251376805.
Bachhuber MA, Cunningham CO, Lincourt P, Jordan AE (2026).
Estimation and comparison of travel burden to outpatient, opioid treatment program, and residential substance use disorder treatment programs
Substance Use & Addiction Journal, 47 (2), 556-563. doi: 10.1177/29767342251370825. PMCID: PMC12628824.
Estimation and comparison of travel burden to outpatient, opioid treatment program, and residential substance use disorder treatment programs
Substance Use & Addiction Journal, 47 (2), 556-563. doi: 10.1177/29767342251370825. PMCID: PMC12628824.
Notable
Incidence and prevalence of hepatitis C virus infection among persons who inject drugs in New York City: 2006-2013
Drug and Alcohol Dependence, 152, 194-200. doi: 10.1016/j.drugalcdep.2015.03.039. PMCID: PMC4458155.
Hagan H, Jordan AE, Neurer J, Cleland CM (2015).
Incidence of sexually transmitted hepatitis C virus infection in HIV-positive men who have sex with men
AIDS, 29 (17), 2335-2345. doi: 10.1097/QAD.0000000000000834. PMCID: PMC4640945.
Perlman DC, Jordan AE, Uuskula A, Huong DT, Masson CL, Schackman BR, Des Jarlais DC (2015).
An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential
International Journal of Drug Policy, 26 (11), 1056-1063. doi: 10.1016/j.drugpo.2015.04.015. PMCID: PMC4581906.
Ashly Jordan's MyBibliography Profile